Funding successes: October and November 2019

Well done to Prof Guy Rutter on his new funding success.

Congratulations to all Principal Investigators in the Department who have recently been awarded research grants. Here is our monthly round-up of funding successes*.

Proposal Dept/Group Infoed PI Name Student Infoed Original Sponsor Funding Scheme Infoed Awarded Value*
Epigenomics and Disease Ferrer, Professor Jorge Imperial College London Diabetes Centre 376,508
Computational and Systems Medicine Li, Dr Jia University Of Khon Kaen 21,100
Diabetes Endocrinology and Metabolic Medicine Oliver, Professor Nick Imperial College London Diabetes Centre ICLDC Research and Innovation Funding Programme – Proposal for Research and Innovation Project 60,521
Computational and Systems Medicine Gooderham, Professor Nigel Medical Research Council (MRC) Integrative Toxicology Training Partnership (ITTP) Studentship 105,604
Genomics of Common Disease Froguel, Professor Philippe Medical Research Council (MRC) Neurosciences & Mental Health Board (NMHB) 672,401
Cell Biology Rutter, Professor Guy Sun Pharmaceutical Industries Limited New Industry Funder – Sun-Pharma (www.sunpharma.com) 232,800
Gastroenterology Thursz, Professor Mark Imperial College Healthcare NHS Trust: Research Capability Funding (RCF) Senior Investigator Award 60,000
Institute of Reproductive and Developmental Biology Male, Dr Victoria Wellcome Trust Transfer from UCL 268,520
Institute of Reproductive and Developmental Biology Lees, Professor Christoph Roche Diagnostics International Ltd 53,293
CSM and Bioinformatics Griffin, Professor Julian Zoe Hall Analytical Chemistry Trust Fund CAMS Fellowship 30,000

*Dude, where’s my grant? A disclaimer:

To ensure the quality and accuracy of the information published on this blog, we source our data directly from the College’s strategic reporting dashboards, relating to FoM. This means that, typically, we only include awards on this list which have been set up on the College’s grants management system, in accordance with the Joint Research Office’s policies and processes. As a result, there may be a delay in promoting some awards.